[Problems in treating patients with chronic HCV infection due to the COVID-19 pandemic and during the lockdown phase

Dietrich Hüppe1, Claus Niederau2, Yvonne Serfert3

  • 1Gastroenterologische Gemeinschaftspraxis Herne, Herne, Deutschland.

Zeitschrift Fur Gastroenterologie
|November 9, 2020
PubMed

Insights

The COVID-19 pandemic disrupted chronic hepatitis C care in Germany, with reduced consultations and antiviral treatments. Delayed diagnoses of liver decompensation and cancer raise significant concerns despite most centers reporting no long-term issues.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic imposed unprecedented challenges on healthcare systems globally.
  • Lockdown regulations significantly impacted routine medical services, including those for chronic conditions.

Purpose of the Study:

  • To analyze the influence of the COVID-19 pandemic on the healthcare of patients with chronic hepatitis C in Germany.
  • To assess the impact of pandemic-related disruptions on diagnosis, therapy, and monitoring of hepatitis C patients.

Main Methods:

  • A structured online questionnaire survey was distributed to centers participating in the German Hepatitis C-Registry (DHC-R).
  • Data were collected from 64 centers regarding consultation changes, patient-initiated cancellations, telehealth adoption, and treatment modifications between March and May 2020.

Main Results:

  • 11% of centers stopped regular consultations, and 58% reduced them during lockdown; over 50% of cancellations were patient-initiated.
  • New antiviral treatments decreased significantly compared to 2019, while telehealth options like telephone and video consultations were introduced.
  • Delayed diagnoses of liver decompensation (22%) and hepatocellular carcinoma (9.4%) were reported, alongside concerns about personal protective equipment availability (56%).

Conclusions:

  • Diagnosis, therapy, and monitoring for chronic hepatitis C patients were negatively affected during the COVID-19 pandemic.
  • While most centers anticipate no medium-to-long-term healthcare problems, delayed diagnoses of potentially fatal liver decompensations are a major concern.
  • The study highlights the need for resilient healthcare strategies to ensure continuous care for chronic conditions during public health crises.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
116
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
567
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
192
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.6K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
91
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
92